Franklin Genomic Advancements ETF
HELX
Market cap $10.9M

27.24 USD

+0.00

0.00%

At close Apr 30, 4:00 PM EDT

1 day

0.00%

5 days

1.87%

1 month

0.89%

3 months

-11.76%

6 months

-11.39%

Year to date

-6.13%

1 year

-9.38%

5 years

3.06%

10 years

13.69%

Funds holding %

of 7,425 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

92% more capital invested

Capital invested by funds: $1.55M [Q3] → $2.97M (+$1.43M) [Q4]

67% more funds holding

Funds holding: 6 [Q3] → 10 (+4) [Q4]

7.01% more ownership

Funds ownership: 15.89% [Q3] → 22.9% (+7.01%) [Q4]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for HELX.

See Analyst Rankings

Financial journalist opinion

Neutral

Seeking Alpha

2 months ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

See News Rankings

Charts implemented using Lightweight Charts™